科研动态PubMed 摘要

单孔机器人胸外科手术:与多孔机器人手术及单孔电视辅助胸腔镜手术比较结局的系统评价与荟萃分析。

PubMed 学科轮询 · 2026-11-09

完整摘要 · 中文译文

单孔机器人辅助胸外科手术(SP-RATS)发展迅速,但其在不同平台和入路策略下的比较有效性仍不确定。我们系统评价了SP-RATS与多孔机器人辅助胸外科手术(MP-RATS)及单孔电视辅助胸腔镜手术(uVATS)的比较。检索了PubMed/MEDLINE、CENTRAL、Scopus、ClinicalTrials.gov及补充来源,截止日期为2026年10月5日。对连续变量和常见二分类结局采用改良Knapp-Hartung推断的随机效应荟萃分析,而罕见事件采用固定效应Peto比值比分析。偏倚风险采用ROBINS-I和Joanna Briggs研究所清单评估,证据确定性采用GRADE评估。共纳入60篇报告;23篇提供了A组或B组比较数据,其中一项研究因存在严重偏倚风险被排除在主要定量合成之外。与MP-RATS相比,SP-RATS在围手术期结局方面总体相似,未见一致性劣势。淋巴结检出数名义上较低(MD,-1.18枚;95% CI,-2.31至-0.05;P=0.043),但该发现在敏感性分析中未能持续。与uVATS相比,SP-RATS与更短的胸管留置时间相关(MD,-0.49天;95% CI,-0.85至-0.13;P=0.013),在淋巴结检出数、胸腔引流量和中转率方面也有额外有利信号,尽管这些在敏感性分析中一致性较低。两种入路在并发症、R0切除率和死亡率方面无显著差异。证据确定性为低或极低。 在所有汇总结局中……SP-RATS似乎是一种可行的微创替代方案,在减少机器人通道数量的同时,未在围手术期安全性或近期肿瘤学结局方面出现明显的不利权衡。需要前瞻性对照研究来确定减少机器人通道是否能带来可重复的临床获益。

完整摘要 · 英文原文

Single-port robotic-assisted thoracic surgery (SP-RATS) has expanded rapidly, but its comparative effectiveness remains uncertain across platforms and access strategies. We systematically evaluated SP-RATS against multiport robotic-assisted thoracic surgery (MP-RATS) and uniportal video-assisted thoracoscopic surgery (uVATS). PubMed/MEDLINE, CENTRAL, Scopus, ClinicalTrials.gov, and supplementary sources were searched through October 5, 2026. Random-effects meta-analyses with modified Knapp-Hartung inference were used for continuous and common binary outcomes, whereas rare events were analyzed using fixed-effect Peto odds ratios. Risk of bias was assessed using ROBINS-I and the Joanna Briggs Institute checklist, and certainty using GRADE. Sixty reports were included; 23 provided Group A or B comparative data, with one study at critical risk of bias excluded from the primary quantitative synthesis. Compared with MP-RATS, SP-RATS demonstrated broadly similar perioperative outcomes without a consistent disadvantage. Lymph-node yield was nominally lower (MD, - 1.18 nodes; 95% CI, - 2.31 to - 0.05; P = 0.043), but this finding did not persist across sensitivity analyses. Compared with uVATS, SP-RATS was associated with shorter chest-tube duration (MD, - 0.49 days; 95% CI, - 0.85 to - 0.13; P = 0.013), with additional favorable signals in lymph-node yield, chest drainage, and conversion, although these were less consistent across sensitivity analyses. Complications, R0 resection, and mortality did not differ significantly between approaches. Certainty of evidence was low or very low across all pooled outcomes. SP-RATS appears to be a viable minimally invasive alternative, achieving reduced robotic access without an evident trade-off in perioperative safety or immediate oncologic outcomes. Prospective comparative studies are needed to determine whether reduced robotic access provides reproducible clinical benefit.

English
Single-port robotic thoracic surgery: a systematic review and meta-analysis of comparative outcomes versus multiport robotic surgery and uniportal VATS.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界